Skip to content
POM-V Prescription Required Companion Animal

Nimatek 100 mg/ml Solution for Injection for Dogs, Cats and Horses

Active ingredient: Ketamine

Form

Injection

Species

Cats Dogs Horses

Manufacturer

Eurovet Animal Health B.V.

VMD MA No.

16849/5001

What it's used for

The veterinary medicinal product may be used to induce anaesthesia: a) in conjunction with butorphanol and medetomidine in the dog and cat, b) in conjuncti...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Ketamine

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Nimatek 100 mg/ml Solution for Injection for Dogs, Cats and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

The veterinary medicinal product may be used to induce anaesthesia:
a) in conjunction with butorphanol and medetomidine in the dog and cat,
b) in conjunction with xylazine in the dog, cat and horse,
c) in conjunction with detomidine in the horse,
d) in conjunction with romifidine in the horse.
Based on a benefit/risk assessment performed by the veterinarian the veterinary
medicinal product may also be used as a sole agent for restraint and minor surgical
procedures where muscle relaxation is not required in the domestic cat.
Do not use in animals with hepatic or renal failure.
Do not use ketamine as a sole agent in the horse or the dog.
Do not use in animals with severe cardiac de-compensation, apparent high blood
pressure or glaucoma.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.

Amended pages: July 2023
AN. 00608/2022
Dogs:
Rare
(1 to 10 animals / 10,000
animals treated):
Hypertonia (of skeletal muscles).
Ataxia, hyperaesthesia, excitation (as emergence
reactions during recovery).
Undetermined frequency
(cannot be estimated from the
available data):
Increased heart rate, increased arterial blood
pressure/hypertension (with concurrent increased
bleeding tendency).
Eyes remain open with mydriasis and nystagmus.
Injection site pain (on intramuscular injection).
Respiratory depression
a
.
Cats:
Rare
(1 to 10 animals / 10,000
animals treated):
Hypertonia (of skeletal muscles).
Ataxia, hyperaesthesia, excitation (as emergence
reactions during recovery).
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Hypersalivation.Undetermined frequency
(cannot be estimated from the
available data):
Increased heart rate, increased arterial blood
pressure/hypertension (with concurrent increased
bleeding tendency).
Eyes remain open with mydriasis and nystagmus.
Injection site pain (on intramuscular injection).
Respiratory depression
a
.
Twitching (muscle tremor), tonic seizures (mild)
b
.

Amended pages: July 2023
AN. 00608/2022
Horses:
Rare
(1 to 10 animals / 10,000
animals treated):
Hypertonia (of skeletal muscles).
Ataxia, hyperaesthesia, excitation (as emergence
reactions during recovery).
Undetermined frequency
(cannot be estimated from the
available data):
Increased heart rate, increased arterial blood
pressure/hypertension (with concurrent increased
bleeding tendency).
Injection site pain (on intramuscular injection).
Respiratory depression
a
.
a
Dose-related, may lead to respiratory arrest particularly in cats. Combination with
respiratory depressant products may increase this respiratory effect.
b
These subside spontaneously but may be prevented by use of acepromazine or
xylazine premedication, or controlled by use of acepromazine or ultra-short acting
barbiturates in low doses.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See package leaflet for respective contact details.
For very painful and major surgical interventions, as well as for maintenance of
anaesthesia, a combination with injectable or inhalation anaesthetics is necessary.
As muscle relaxation required for surgical procedures cannot be achieved with
ketamine alone, additional muscle-relaxants should be used concomitantly. For
improvement of anaesthesia or prolongation of effect ketamine can be combined with
α2-receptor-agonists, anaesthetics, neuroleptanalgesics, tranquillisers and
inhalational anaesthetic agents. It should be noted that time-to-full-effect may be
prolonged when using the subcutaneous administration route in cats.

Special precautions for use in animals
A small proportion of animals have been reported to be unresponsive to ketamine as
an anaesthetic agent at normal dosages. Use of premedicants should be followed by
a suitable reduction in dosage.
Induction and recovery should be allowed to occur in quiet and calm surroundings.
As with all anaesthetics, animals should be fasted for an appropriate duration (as
determined by the responsible veterinary surgeon) prior to ketamine
anaesthesia.Atropine premedication may reduce salivation in cats. Since use of
atropine with alpha-2-agonists, which are often administered with ketamine, may
increase arterial blood pressure, heart rate and the incidence of arrhythmias, atropine
premedication should only be used according to a benefit:risk assessment by the
responsible veterinarian.
Muscular twitching and mild tonic convulsions have been reported in the cat at
recommended dose rates. These subside spontaneously but may be prevented by
use of acepromazine or xylazine premedication, or controlled by use of
acepromazine or ultra-short acting barbiturates in low doses.
In the cat and dog, the eyes remain open and the pupils dilated. The eyes may be
protected by covering with a damp gauze swab or using appropriate ointments.
Ketamine may exhibit pro-convulsant and anti-convulsant properties, and therefore
should be used with care in patients with seizure disorders.
Ketamine may increase intracranial pressure and therefore, may not be suitable for
patients with cerebrovascular insults.
When used in combination with other products, consult the contraindications and
warnings that appear on the relevant data sheets.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This is a potent drug. Particular care should be taken to avoid accidental self-
administration. Preferably use a guarded needle until the moment of injection.
People with known hypersensitivity to ketamine or any of the excipients should avoid
contact with the veterinary medicinal product.
Avoid contact with the skin and eyes. Wash any splashes from skin and eyes
immediately with large amounts of water.
Adverse effects on the foetus cannot be excluded. The veterinary medicinal product
should not be administered by pregnant women.
In case of accidental self-injection or if symptoms occur after ocular/oral contact,
seek medical advice immediately and show the package leaflet or the label to the
physician, but DO NOT DRIVE.

Amended pages: July 2023
AN. 00608/2022
Advice to doctors:
Do not leave patient unattended. Maintain airways and give symptomatic and
supportive treatment.
Special precautions for the protection of the environment:
Not applicable.
Care should be taken when using ketamine-halothane combinations since half-life of
ketamine is prolonged. Neuroleptanalgesics, tranquilizers and chloramphenicol
potentiate ketamine anaesthesia. Barbiturates and opiates can prolong the recovery
period. Ketamine has been reported to enhance the occurrence of tachycardia and
hypertension when used in human patients receiving thyroid hormones.
Excipient:
Chlorocresol 1 mg
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.